Literature DB >> 28206982

Biocompatible chitosan nanoparticles as an efficient delivery vehicle for Mycobacterium tuberculosis lipids to induce potent cytokines and antibody response through activation of γδ T cells in mice.

Ishani Das1, Avinash Padhi, Sitabja Mukherjee, Debi P Dash, Santosh Kar, Avinash Sonawane.   

Abstract

The activation of cell-mediated and humoral immune responses to Mycobacterium tuberculosis (Mtb) is critical for protection against the pathogen and nanoparticle-mediated delivery of antigens is a more potent way to induce different immune responses. Herein, we show that mice immunized with Mtb lipid-bound chitosan nanoparticles (NPs) induce secretion of prominent type-1 T-helper (Th-1) and type-2 T-helper (Th-2) cytokines in lymph node and spleen cells, and also induces significantly higher levels of IgG, IgG1, IgG2 and IgM in comparison to control mice. Furthermore, significantly enhanced γδ-T-cell activation was observed in lymph node cells isolated from mice immunized with Mtb lipid-coated chitosan NPs as compared to mice immunized with chitosan NPs alone or Mtb lipid liposomes. In comparison to CD8+ cells, significantly higher numbers of CD4+ cells were present in both the lymph node and spleen cells isolated from mice immunized with Mtb lipid-coated chitosan NPs. In conclusion, this study represents a promising new strategy for the efficient delivery of Mtb lipids using chitosan NPs to trigger an enhanced cell-mediated and antibody response against Mtb lipids.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28206982     DOI: 10.1088/1361-6528/aa60fd

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  8 in total

1.  Molecular insight to size and dose-dependent cellular toxicity exhibited by a green synthesized bioceramic nanohybrid with macrophages for dental applications.

Authors:  Hardik Makkar; Suresh K Verma; Pritam Kumar Panda; Nandini Pramanik; Ealisha Jha; Mrutyunjay Suar
Journal:  Toxicol Res (Camb)       Date:  2018-06-19       Impact factor: 3.524

Review 2.  Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Authors:  Anke Osterloh
Journal:  Vaccines (Basel)       Date:  2022-05-10

Review 3.  Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases.

Authors:  Lampouguin Yenkoidiok-Douti; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2020-01-12

Review 4.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

Review 5.  The Impact of Nanoparticles on Innate Immune Activation by Live Bacteria.

Authors:  Benjamin J Swartzwelter; Alexandra C Fux; Litty Johnson; Elmer Swart; Sabine Hofer; Norbert Hofstätter; Mark Geppert; Paola Italiani; Diana Boraschi; Albert Duschl; Martin Himly
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

Review 6.  Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis.

Authors:  Jorge Matías-Guiu; Jordi A Matías-Guiu; Paloma Montero-Escribano; Juan A Barcia; Alejandro A Canales-Aguirre; Juan C Mateos-Diaz; Ulises Gómez-Pinedo
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

Review 7.  Nanoparticle Vaccines Against Infectious Diseases.

Authors:  Rashmirekha Pati; Maxim Shevtsov; Avinash Sonawane
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

Review 8.  Advancements in prophylactic and therapeutic nanovaccines.

Authors:  Prateek Bhardwaj; Eshant Bhatia; Shivam Sharma; Nadim Ahamad; Rinti Banerjee
Journal:  Acta Biomater       Date:  2020-04-05       Impact factor: 10.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.